Viral isolates associated with multiple sclerosis

US6184025A · kind A · utility

Assignee

• BIOMERIEUX, INC. · FR

Inventors

• Herve Perron · Val-de-Reuil, FR
• Francois Mallet · Villeurbanne, FR
• Bernard Mandrand · Villeurbanne, FR
• Frederic Bedin · Val-de-Reuil, FR
• Frederic Beseme · Villefontaine, FR

Key dates

• Filing date: Nov 30, 1998
• Grant date: Feb 6, 2001
• Expiry date: Nov 30, 2018

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S435/912
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Composition comprising two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of said virus, and a second agent, or a variant of said second agent, these two pathogenic and/or infective agents originating from the same viral strain chosen from the strains designated, respectively, POL-2 deposited with the ECACC on Jul. 22, 1992 under Accession Number V92072202 and MS7PG deposited with the ECACC on Jan. 8, 1993 under Accession Number V93010816, and from their variant strains.